Relationship between peripheral monocytosis and nonrecovery of left ventricular function in patients with left

Young Joon Hong1, Myung Ho Jeong, Youngkeun Ahn

  • 1The Heart Center of Chonnam National University Hospital, Chonnam National University Research Institute of Medical Sciences, Gwangju, Korea.

Insights

Older age and high monocyte counts predict poor left ventricular function recovery after heart attack. These factors are crucial for understanding chronic ischemic heart failure post-treatment.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Biomedical Research

Background:

  • Ischemic heart failure is a leading cause of mortality post-acute myocardial infarction (AMI).
  • Factors influencing left ventricular function (LVF) recovery after AMI remain unclear.
  • Left ventricular dysfunction (LVEF < 40%) post-AMI requires identification of recovery predictors.

Purpose of the Study:

  • Identify predictors of nonrecovery of LVF in patients with LV dysfunction post-AMI.
  • Investigate the role of baseline characteristics in predicting LVF recovery after primary PCI.
  • Determine independent predictors for chronic ischemic heart failure development.

Main Methods:

  • Retrospective analysis of 108 patients with LV dysfunction post-AMI and successful primary PCI.
  • Patients divided into LVF recovery (n=64) and non-recovery (n=44) groups.
  • Echocardiographic LVEF measured at baseline and 8±4 months post-PCI; correlation and multivariate analyses performed.

Main Results:

  • Patients without LVF recovery were significantly older and had higher baseline monocyte, creatine kinase, and troponin I levels.
  • Baseline peak monocyte count, creatine kinase, and troponin I levels correlated with reduced LVEF improvement.
  • Multivariate analysis identified older age and higher baseline peak monocyte count as independent predictors of nonrecovery of LVF.

Conclusions:

  • Peripheral monocytosis is associated with nonrecovery of LVF in patients with LV dysfunction post-AMI.
  • Monocytes may play a significant role in infarct expansion and chronic ischemic heart failure development.
  • These findings highlight potential therapeutic targets for improving outcomes after reperfusion therapy.
Abstract

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...